Tiny Microchip Company May Have Figured Out How To “Delete” Disease – Billionaire Investors Rush In

Take a look at this strange code:

Believe it or not – that’s a sequence of digitized DNA.

Now watch this:

See that highlighted area in blue? That’s cancer.

And it’s just been deleted.

Dr. Eric Pierce says, “Once the [DNA] is edited, it’s permanent and [should] persist for the life of the patient.”

John Sculley, Former Apple CEO says this “Has the potential to cure 85% of cancers within five years and to cure people with stage four lung cancer in a matter of weeks.”

And Vanguard’s global Head of Investment says, “If I had to pick one field that was going to be bigger than the Internet it would be [this] technology.”

So it’s no wonder that the world’s richest billionaires are rushing to get a piece this little-known company.

  • Jeff Bezos just added $100 million.
  • Bill Gates’ fund is throwing in $429 million and says it’s “one of the most powerful technologies of the 21st century.”
  • Mark Zuckerberg’s $3 billion fund just backed it.
  • And Peter Thiel – a man that Forbes, Fortune, and The New Yorker all call the best tech investor in history…he just added $110 million.

Fortunately, it’s not too late for “the little guy” to get a piece of the action as well.

This company’s stock is still only trading for around $2 per share, and I believe it’s set to lead an industry with a projected 200,000% growth over the next 5 years alone.

That means even a modest grubstake could turn into a small fortune.

This could be the biggest mega-trend of the next two decades and right now it’s still possible to get in early.

Get the urgent details on this company by simply entering your email address below for immediate access.

Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Profitable News permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works